Proteomic approaches for investigation of therapy resistance in cancer (Q39959305)

15 September 2017

title

Proteomic approaches for investigation of therapy resistance in cancer (English)

1 reference

15 September 2017

Hermann Lage

1

1 reference

15 September 2017

publication date

1 August 2009

1 reference

Proteomics - Clinical Applications

15 September 2017

published in

1 reference

15 September 2017

volume

3

1 reference

15 September 2017

issue

8

1 reference

15 September 2017

page(s)

883-911

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

15 September 2017

1 reference

Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

Overexpression of the 27 KDa heat shock protein is associated with thermoresistance and chemoresistance but not with radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

Overexpression of cell surface cytokeratin 8 in multidrug-resistant MCF-7/MX cells enhances cell adhesion to the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.200800162

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/44188

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1200/JCO.2006.06.3743

Identifiers

DOI

10.1002/PRCA.200800162

1 reference

15 September 2017

1 reference